tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MESO Stock Latest News

Mesoblast options imply 11.6% move in share price post-earnings
The FlyMesoblast options imply 11.6% move in share price post-earnings
3h ago
MESO
Mesoblast downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Mesoblast downgraded to Hold from Buy at Jefferies
1M ago
MESO
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
PremiumThe Fly
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
1M ago
MESO
Mesoblast Announces Cessation of Securities and Capital Adjustments
PremiumCompany Announcements
Mesoblast Announces Cessation of Securities and Capital Adjustments
1M ago
6K
MESO
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
PremiumRatings
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
2M ago
MESO
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
PremiumThe FlyMesoblast gives update on Revascor accelerated approval, Ryoncil label extension
3M ago
MESO
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
MESO
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
Premium
The Fly
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
4M ago
MESO
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
PremiumThe Fly
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
4M ago
MESO
Mesoblast Updates Securities Status with ASX
PremiumCompany Announcements
Mesoblast Updates Securities Status with ASX
5M ago
6K
MESO
Mesoblast Announces Director Securities Changes Following AGM Approval
PremiumCompany Announcements
Mesoblast Announces Director Securities Changes Following AGM Approval
5M ago
6K
MESO
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
PremiumThe Fly
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
5M ago
MESO
Mesoblast added to S&P/ASX 200 index
PremiumThe FlyMesoblast added to S&P/ASX 200 index
6M ago
MESO
Mesoblast’s Earnings Call: RYONCIL Approval & Growth
Premium
Company Announcements
Mesoblast’s Earnings Call: RYONCIL Approval & Growth
6M ago
MESO
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
Premium
Ratings
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
6M ago
MESO
Mesoblast Reports FDA Approval and Financial Results
PremiumCompany Announcements
Mesoblast Reports FDA Approval and Financial Results
6M ago
MESO
Mesoblast Appoints Dr. Gregory George to Board, Enhancing Strategic and Operational Expertise
PremiumCompany Announcements
Mesoblast Appoints Dr. Gregory George to Board, Enhancing Strategic and Operational Expertise
6M ago
6K
MESO
Mesoblast price target raised to $24 from $15 at Piper Sandler
PremiumThe Fly
Mesoblast price target raised to $24 from $15 at Piper Sandler
7M ago
MESO
Mesoblast provides update on progress of U.S. commercial launch of Ryoncil
PremiumThe Fly
Mesoblast provides update on progress of U.S. commercial launch of Ryoncil
7M ago
MESO
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
ALT
QSI
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
8M ago
DNA
AISP
Mesoblast Stock Rockets to New 52-Week High
Premium
Market News
Mesoblast Stock Rockets to New 52-Week High
8M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >